Elsevier

Brain Research

Volume 841, Issues 1–2, 11 September 1999, Pages 193-196
Brain Research

Short communication
TTX blocks baclofen-induced phase shifts of the mammalian circadian pacemaker in vitro

https://doi.org/10.1016/S0006-8993(99)01791-6Get rights and content

Abstract

The mammalian circadian pacemaker, located in the suprachiasmatic nucleus (SCN), expresses 24-h rhythms when isolated in vitro. The GABAA agonist, muscimol, induces phase advances during the mid-subjective day, while the GABAB agonist, baclofen, induces both daytime phase advances and nighttime phase delays. Here, we present evidence that tetrodotoxin (TTX) completely blocks baclofen-induced phase shifts in vitro, but does not block in vitro phase advances induced by muscimol. These results suggest that GABAA, but not GABAB, receptors are located on SCN pacemaker cells.

Section snippets

Acknowledgements

This research was supported by NIH grant MH53317 to R.A.P.

Cited by (0)

View full text